|
|
NEUROENDOCRINOLOGY
LETTERS
including Psychoneuroimmunology, Neuropsychopharmacology,
Reproductive Medicine, Chronobiology
and
Human Ethology
ISSN 0172780X
|
|
Pressreleases
Next
coming issues |
PRESS RELEASE
17-Sep-2004
|
to
be published in the next coming issue
Vol.25
No. 5, 2004
|
|
|
Wei
Zhu, Kirk J. Mantione and George B. Stefano
at the Neuroscience Research Institute, State University
of New York College at Old Westbury have demonstrated
that animal neural tissues can make morphine. Given the presence
of morphine, its metabolites and precursors in mammalian and
invertebrate tissues, it became important to determine if
exposing tissues to an opiate alkaloid precursor, reticuline,
would result in increasing endogenous morphine levels. Endogenous
morphine levels were determined by high pressure liquid chromatography
coupled to electrochemical detection and radioimmunoassay
following incubation of Mytilus edulis pedal ganglia with
reticuline. Nitric oxide (NO) release was determined in real-time
via an amperometric probe. Mu opiate receptor affinity for
opiate alkaloid precursors was determined by a receptor displacement
assay. Morphine is present in the pedal ganglia of Mytilus
edulis (1.43 ± 0.41 ng/mg ± SEM ganglionic wet
weight). Ganglia incubated with 50 ng of reticuline, a morphine
precursor in plants, for 1 hour exhibited a statistical increase
in their endogenous morphine levels (6.7 ± 0.7 ng/mg
tissue wet weight ; P<0.01). This phenomenon is concentration
dependent. The increase in ganglionic morphine levels occurs
gradually over the 60 min incubation period, beginning 10
minutes post reticuline addition. They show that reticuline
(10-6 M) does not stimulate ganglionic NO release in a manner
resembling that of morphine (10-6 M), which releases NO seconds
after its exposure to the ganglia and lasts for 5 minutes.
With reticuline, there is a 3 minute delay, which is followed
by an extended release period. Furthermore, in binding displacement
experiments both reticuline and salutaridine (another morphine
precursor) exhibit no binding affinity for the pedal ganglia
mu opiate receptor subtype. This finding is further substantiated
using the positive control of human monocytes where the mu3
opiate receptor subtype has been cloned.
Taken together, they surmise that the morphine's precursors
are being converted to morphine. The experiments show that
pedal ganglia can synthesize morphine from reticuline.
Full
text published in the October issue,
Vol. 25 No.5, 2004
Neuroendocrinology
Letters
www.nel.edu
|
__________________________________________________________
Copyright © Neuroendocrinology Letters 2004
All rights reserved. No part may be reproduced, stored in a retrieval
system, or transmitted in any form or by any means, electronic,
mechanical, photocopying, recording, or ortherwise, without prior
written permission from the Editor-in-Chief. |
|
|